SCHEMBL18091995

SCHEMBL18091995

CCCCc1noc(C)c1/C=C/c1nc(C)c(OC(=O)NC2CCCC2O)s1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GABRA5 P31644 8/20 0.31
CNR1 P21554 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18092055 1.00 GABRA5 (0.31) GABRA5CNR1
SCHEMBL18092059 0.90 CNR2 (0.33) CNR1
SCHEMBL18092013 0.88 CHRM4 (0.31)
SCHEMBL285740 0.85 CNR1 (0.34) GABRA5CNR1
SCHEMBL295219 0.85 CNR1 (0.34) GABRA5CNR1
SCHEMBL5535152 0.85 CNR1 (0.34) GABRA5CNR1
SCHEMBL18091982 0.85 GABRA5 (0.35) GABRA5
SCHEMBL18091994 0.84 CHRM4 (0.34) GABRA5
SCHEMBL18092007 0.83 TP53 (0.31)
SCHEMBL18091976 0.83 ACACB (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2427459-B1 ISOXAZOLE-THIAZOLE DERIVATIVES AS GABA A RECEPTOR INVERSE AGONISTS FOR USE IN THE TREATMENT OF COGNITIVE DISORDERS HOFFMANN LA ROCHE (CH) 2016-09-28 EP claimed